• 
• http://www.nature.com/nrclinonc
• Editor: Vincent T. DeVita, Jr., MD
• Volume 6: 12 issues per year
• ISSN: 1759-4774
• EISSN: 1759-4782
• Impact factor : 9.113*
• Impact ranking: 8/141 in Oncology*
• Date Established: November 2004
• Published on behalf of: In collaboration with the European School of Oncology

Aims and Scope:
Nature Reviews Clinical Oncology is a peer-reviewed journal for oncologists and affiliated health-care professionals. The journal delivers timely interpretations of key scientific developments in oncology and related areas of study.

Nature Reviews Clinical Oncology is published monthly in print and online, and includes commissioned news, commentary and opinion pieces, comprehensive reviews, and in-depth case studies. Articles are subject to rigorous peer-review and/or review by in-house editors.

Topics covered include pathology, diagnosis, treatment (e.g chemotherapy, radiotherapy, surgery), prevention, and palliative care of all types of human malignant disease.

Readership:
Academics, clinicians, researchers (students, post-doctoral researchers and senior scientists) and other health-care professionals in cancer medicine, including hematologists, radiologists, and general surgeons, as well as commercial and government organizations involved in drug development and clinical trials.

Online features and site license access:

• Online archive available back to November 2004.
• A site license provides access to all content published during the supply period. Access is granted to a further rolling four-year archive during the supply period only. Archive content not included in the license agreement is available to purchase.
• Indexed in CAB Abstracts, Chemical Abstracts Service (CAS), Cumulative Index to Nursing and Allied Health Literature (CINAHL), Current Contents®/Clinical Medicine, EMBASE, Excerpta Medica, Index Medicus/MEDLINE, ISI web of knowledge (Science Citation Index Expanded) and PubMed.

*2008 Journal Citation Report (Thomson Reuters, 2009). Nature Clinical Practice Oncology will continue to receive impact factors until June 2012. Nature Reviews Clinical Oncology will receive its first impact factor in June 2011; the values will be 'unified' for publication in 2011 and 2012.